Cleveland Clinic Is Reversing Type 2 Diabetes—With AI, Not GLP-1s

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Brian Walshe a loving husband or wife killer? It's up to the jury now

DEDHAM ‒ “A loving father and husband.” That’s how Brian Walshe’s defense attorney, Larry Tipton, described the Cohasset man ...
The American Journal of Managed Care

Team-Based Strategies Advance Cardio-Renal-Metabolic Health

Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...
Targeted Oncology

FDA Approves Niraparib/Abiraterone Combo for BRCA2-Mutated mCSPC

The FDA approved niraparib and abiraterone acetate plus prednisone for BRCA2-mutated mCSPC, based on the AMPLITUDE trial's rPFS results. FDA approves a new treatment combining niraparib and ...
The Malaysian Reserve

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs ...

Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine ...